NCT00529321View on ClinicalTrials.gov

Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2010

Conditions
Hepatitis C, Chronic
Interventions
BIOLOGICAL

MVA-HCV (Immunotherapy)

MVA-HCV

Trial Locations (6)

38700

Hopital A. Michallon, La Tronche

44000

Hôpital de l'Hôtel Dieu, Nantes

54500

Hôpital de Brabois, Vandœuvre-lès-Nancy

67091

Hopital Civil, Strasbourg

69288

Hopital de l'Hotel-Dieu, Lyon

94010

Hôpital Henri Mondor, Créteil

Sponsors

Lead Sponsor

Transgene
All Listed Sponsors
lead

Transgene

INDUSTRY

NCT00529321 - Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus | Biotech Hunter | Biotech Hunter